MPI STANNOUS DIPHOSPHONATE
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Apr 1977
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 1h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MPI Stannous Diphosphonate is an injectable diagnostic radiopharmaceutical agent approved in 1977 by GE HealthCare. The mechanism of action and specific indications are not publicly detailed in available data, but stannous diphosphonates are typically used in nuclear medicine imaging. This product represents a legacy diagnostic modality now facing significant market pressure.
LOE Approaching
As a legacy injectable diagnostic product with approaching loss of exclusivity and zero linked job openings, this brand operates with minimal commercial infrastructure and limited growth opportunity.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings indicate minimal active career development on this product. Working on MPI Stannous Diphosphonate would involve maintaining a legacy product rather than driving growth or innovation. Career advancement opportunities are severely limited, and this role would be most suitable for professionals seeking operational or compliance stability rather than commercial growth.
Regulatory Affairs (legacy compliance)
Worked on MPI STANNOUS DIPHOSPHONATE at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.